152 related articles for article (PubMed ID: 33363953)
1. Response to PD-1 blockade in a patient with mucosal melanoma of the middle ear: Case report.
Komatsuda H; Kumai T; Ueda S; Hirata-Nozaki Y; Hayashi T; Harabuchi Y
Clin Case Rep; 2020 Dec; 8(12):3468-3471. PubMed ID: 33363953
[TBL] [Abstract][Full Text] [Related]
2. Primary Middle Ear Mucosal Melanoma: Case Report and Comprehensive Literature Review of 21 Cases of Primary Middle Ear and Eustachian Tube Melanoma.
Maxwell AK; Takeda H; Gubbels SP
Ann Otol Rhinol Laryngol; 2018 Nov; 127(11):856-863. PubMed ID: 30103615
[TBL] [Abstract][Full Text] [Related]
3. Comparative investigation of cell cycle and immunomodulatory genes in mucosal and cutaneous melanomas: Preliminary data suggest a potential promising clinical role for p16 and the PD-1/PD-L1 axis.
Wrede N; Hoffmann I; Vollbrecht C; Koch I; Wolkenstein P; Klauschen F; Capper D; von Laffert M; Jurmeister P
Pathol Res Pract; 2022 Jan; 229():153689. PubMed ID: 34844086
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of anti-PD-1 agents in acral and mucosal melanoma.
Shoushtari AN; Munhoz RR; Kuk D; Ott PA; Johnson DB; Tsai KK; Rapisuwon S; Eroglu Z; Sullivan RJ; Luke JJ; Gangadhar TC; Salama AK; Clark V; Burias C; Puzanov I; Atkins MB; Algazi AP; Ribas A; Wolchok JD; Postow MA
Cancer; 2016 Nov; 122(21):3354-3362. PubMed ID: 27533633
[TBL] [Abstract][Full Text] [Related]
5. Mucosal Melanoma: a Literature Review.
Yde SS; Sjoegren P; Heje M; Stolle LB
Curr Oncol Rep; 2018 Mar; 20(3):28. PubMed ID: 29569184
[TBL] [Abstract][Full Text] [Related]
6. Primary mucosal malignant melanoma of middle ear - A case report.
Mehta BS; Maniyar H
Indian J Otolaryngol Head Neck Surg; 2007 Mar; 59(1):71-2. PubMed ID: 23120394
[TBL] [Abstract][Full Text] [Related]
7. Talimogene Laherparepvec in Advanced Mucosal Melanoma of the Urethra Upon Primary Resistance on Immune Checkpoint Inhibition: A Case Report.
Fröhlich A; Hoffmann F; Niebel D; Egger E; Kukuk GM; Toma M; Sirokay J; Bieber T; Landsberg J
Front Oncol; 2020; 10():611. PubMed ID: 32457834
[No Abstract] [Full Text] [Related]
8. Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma.
Klemen ND; Wang M; Rubinstein JC; Olino K; Clune J; Ariyan S; Cha C; Weiss SA; Kluger HM; Sznol M
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32209601
[TBL] [Abstract][Full Text] [Related]
9. Variable indoleamine 2,3-dioxygenase expression in acral/mucosal melanoma and its possible link to immunotherapy.
Iga N; Otsuka A; Hirata M; Kataoka TR; Irie H; Nakashima C; Matsushita S; Uchi H; Yamamoto Y; Funakoshi T; Fujisawa Y; Yoshino K; Fujimura T; Hata H; Ishida Y; Kabashima K
Cancer Sci; 2019 Nov; 110(11):3434-3441. PubMed ID: 31509303
[TBL] [Abstract][Full Text] [Related]
10. Malignant Mucosal Melanoma of the Eustachian Tube With Extension Into the Ipsilateral External Ear Canal: A Case Report and Review of the Literature.
Li L; London NR; Chen X
Ear Nose Throat J; 2021 Sep; 100(5_suppl):730S-733S. PubMed ID: 32070121
[TBL] [Abstract][Full Text] [Related]
11. Primary mucosal malignant melanoma of the middle ear.
Sherman IW; Swift AC; Haqqani MT
J Laryngol Otol; 1991 Dec; 105(12):1061-4. PubMed ID: 1787360
[TBL] [Abstract][Full Text] [Related]
12. JAK2, PD-L1, and PD-L2 (9p24.1) amplification in metastatic mucosal and cutaneous melanomas with durable response to immunotherapy.
Gupta S; Vanderbilt CM; Cotzia P; Arias Stella JA; Chang JC; Chen Y; Tang LH; DeLair DF; Yao J; Ladanyi M; Ross DS
Hum Pathol; 2019 Jun; 88():87-91. PubMed ID: 30236595
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma.
Martins Nascentes Melo L; Herrera-Rios D; Hinze D; Löffek S; Oezel I; Turiello R; Klein J; Leonardelli S; Westedt IV; Al-Matary Y; Egea-Rodriguez S; Brenzel A; Bau M; Sucker A; Hadaschik E; Wirsdörfer F; Hanenberg H; Uhlenbrock N; Rauh D; Poźniak J; Rambow F; Marine JC; Effern M; Glodde N; Schadendorf D; Jablonska J; Hölzel M; Helfrich I
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37028818
[TBL] [Abstract][Full Text] [Related]
14. Primary mucosal melanoma arising from the eustachian tube with CTLA-4, IL-17A, IL-17C, and IL-17E upregulation.
Wei C; Sirikanjanapong S; Lieberman S; Delacure M; Martiniuk F; Levis W; Wang BY
Ear Nose Throat J; 2013 Jan; 92(1):36-40. PubMed ID: 23354891
[TBL] [Abstract][Full Text] [Related]
15. Mucosal melanoma of the middle ear cavity and Eustachian tube: a case report, literature review, and focus on surgical technique.
Peters G; Arriaga MA; Nuss DW; Pou AM; DiLeo M; Scrantz K
Otol Neurotol; 2012 Feb; 33(2):239-43. PubMed ID: 22215460
[TBL] [Abstract][Full Text] [Related]
16. Melanoma subtypes demonstrate distinct PD-L1 expression profiles.
Kaunitz GJ; Cottrell TR; Lilo M; Muthappan V; Esandrio J; Berry S; Xu H; Ogurtsova A; Anders RA; Fischer AH; Kraft S; Gerstenblith MR; Thompson CL; Honda K; Cuda JD; Eberhart CG; Handa JT; Lipson EJ; Taube JM
Lab Invest; 2017 Sep; 97(9):1063-1071. PubMed ID: 28737763
[TBL] [Abstract][Full Text] [Related]
17. [Primitive malignant melanoma of the base of the tongue].
Bovo R; Farruggio A; Agnoletto M; Galceran M; Polidoro F
Acta Otorhinolaryngol Ital; 1996 Aug; 16(4):371-4. PubMed ID: 9082832
[TBL] [Abstract][Full Text] [Related]
18. Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade.
Buchbinder EI; Weirather JL; Manos M; Quattrochi BJ; Sholl LM; Brennick RC; Bowling P; Bailey N; Magarace L; Ott PA; Haq R; Izar B; Giobbie-Hurder A; Hodi FS
Cancer Med; 2021 Apr; 10(8):2627-2635. PubMed ID: 33724703
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcome of PD-1 immune checkpoint inhibitor in Asian metastatic melanoma patients: correlative analysis with PD-L1 immunohistochemistry.
Cho J; Ahn S; Yoo KH; Kim JH; Choi SH; Jang KT; Lee J
Invest New Drugs; 2016 Dec; 34(6):677-684. PubMed ID: 27491654
[TBL] [Abstract][Full Text] [Related]
20. Identification and clinical relevance of PD-L1 expression in primary mucosal malignant melanoma of the head and neck.
Thierauf J; Veit JA; Affolter A; Bergmann C; Grünow J; Laban S; Lennerz JK; Grünmüller L; Mauch C; Plinkert PK; Hess J; Hoffmann TK
Melanoma Res; 2015 Dec; 25(6):503-9. PubMed ID: 26352784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
